About Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome
Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome is a rare disease catalogued by Orphanet (ORPHA:306661). It is associated with the FGF23, GALNT3, KL genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome trials.
Search ClinicalTrials.gov for "Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome" or filter by Orphanet code ORPHA:306661 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome. Updated daily.